What is Esperion Therapeutics' stock symbol?
Esperion Therapeutics trades on the NASDAQ under the ticker symbol "ESPR."
Where is Esperion Therapeutics' stock going? Where will Esperion Therapeutics' stock price be in 2017?
12 brokers have issued 1 year price targets for Esperion Therapeutics' stock. Their predictions range from $12.00 to $67.00. On average, they expect Esperion Therapeutics' stock price to reach $26.54 in the next twelve months.
When will Esperion Therapeutics announce their earnings?
Esperion Therapeutics is scheduled to release their next quarterly earnings announcement on Thursday, February, 23rd 2017.
Who owns Esperion Therapeutics stock?
Esperion Therapeutics' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Pentwater Capital Management LP (8.11%), Discovery Capital Management LLC CT (4.62%), FMR LLC (3.40%), Senzar Asset Management LLC (1.61%), State Street Corp (1.06%) and J. Goldman & Co LP (0.72%). Company insiders that own Esperion Therapeutics stock include Dov A Md Goldstein, Gilbert S Omenn, Mark E Mcgovern, Narendra D Lalwani and Timothy M Mayleben.
Who sold Esperion Therapeutics stock? Who is selling Esperion Therapeutics stock?
Esperion Therapeutics' stock was sold by a variety of institutional investors in the last quarter, including FT Options LLC, Oxford Asset Management, Discovery Capital Management LLC CT, State Street Corp and Martingale Asset Management L P.
Who bought Esperion Therapeutics stock? Who is buying Esperion Therapeutics stock?
Esperion Therapeutics' stock was purchased by a variety of institutional investors in the last quarter, including Senzar Asset Management LLC, Pentwater Capital Management LP, J. Goldman & Co LP, Pinnacle Associates Ltd., Paulson & CO. Inc., Dimensional Fund Advisors LP, Elkfork Partners LLC and Keybank National Association OH. Company insiders that have bought Esperion Therapeutics stock in the last two years include Gilbert S Omenn, Mark E Mcgovern, Narendra D Lalwani and Timothy M Mayleben.
How do I buy Esperion Therapeutics stock?
Shares of Esperion Therapeutics can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Esperion Therapeutics stock cost?
One share of Esperion Therapeutics stock can currently be purchased for approximately $24.37.